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This report details the synthesis and analysis of new β-cyclodextrin (β-CD) networks: 
KβCD-MOF-1, KβCD-MOF-1-Chol and KβCD-MOF-2. Investigations of uptake of four 
sterols have also been conducted. The syntheses of the crystals were achieved by a 
vapour diffusion method at ambient temperature and pressure using mixtures of β-
CD/potassium hydroxide in a ratio of 1:20, β-CD/potassium hydroxide/cholesterol in a ratio 
of 1:20:⅓ and β-CD/potassium benzoate in a ratio of 1:1, respectively. The analysis of 
crystals was performed using nuclear magnetic resonance (NMR) spectroscopy, X-ray 
diffraction (XRD) and optical and scanning electron microscopy. XRD showed KβCD-
MOF-1 was made of accessible β-CD channels with each layer being perpendicular to the 
one above and the one below it. KβCD-MOF-1-Chol had a honeycomb like structure with 
cholesterol present in the β-CD channels. KβCD-MOF-2 was similar to a previously 
reported inclusion complex, although the crystallisation methods used were different. 
Changes to crystal morphology of KβCD-MOF-1 and a control crystal were investigated 
using optical microscopy. The results of overnight soaking of these crystals using 
cholesterol dissolved in ethanol showed KβCD-MOF-1 crystal remained unchanged whilst 
the control crystal had nucleation occur on the edges.  
Four types of sterols (Cholesterol, testosterone, beta-estradiol and deoxycholic acid) were 
used to investigate the uptake ratio of KβCD-MOF-1 and this was achieved using proton 
NMR analysis. The results showed that uptake of these sterols were successful. The NMR 
results also showed an inverse relation between numbers of polar groups in the sterol to 
the uptake by KβCD-MOF-1 network. The ratios of sterols:β-CD were observed to be 1:2, 
1:4, 1:2 and 1:3 for cholesterol, testosterone, beta-estradiol and deoxycholic acid, 
respectively. 
The encapsulations of UiO-66 crystals in to vesicles were investigated using fluorescence 
and electron microscopy. Although fluorescence microscopy provided some evidence of 
encapsulation however it was not confirmed by electron microscopy positively. Therefore 
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1.1 Metal Organic Frameworks 
In the recent years, Metal organic frameworks (MOFs) have attracted considerable 
attention because they combine very high levels of porosity with a range of other 
functional properties that occur through the metal moiety and/or the organic ligands. 
These porous networks bear the potential of revolutionising applications such as 
gas storage and separation, drug delivery, carbon capture, bio-mimetic mineralisation 
or catalysis.[1-18] 
The main constituents of MOFs are metal ions or clusters of metal ions and organic 
ligands or linkers. In order to synthesise MOFs a ligand forms more than one 
coordinate bond (multi-dentate ligands) which allows ligand to bond to several metal 
ions or metal ion clusters. Examples of metal ions or metal ion clusters used for MOFs 
are Zn4O in MOF-5 and Zr6O4(OH)4 cluster in UiO-66.
[19] Figure 1-1 shows an 
example of a zinc-based MOF named MOF-5. 
  
Figure1-1: An example of zinc-based MOF known as MOF-5. It is formed from 




Examples of ligands (Figure 1-2) include molecules such as terephthalic acid 
which is used to make MOF-5.[20] Larger structures such as 2,3,6,7,10,11-
hexaaminotriphenylene (HATP) have also been used to make MOFs which have 
high conductivity.[20] A mixture of ligands can be used to limit or control the 
structure of MOFs as smaller ligands can also be used to ‘cap’ a metal centre so 









(a) HATP (b) Terephthalic acid
 
Figure 1-2: Structures of two ligands (a) HATP and (b) terephthalic acid.  
The differences in shape and size of the ligands and the abundance of the metal 
ions or clusters mean that the combinations of MOFs which can be formed are 
almost limitless. The MOFs are crystalline therefore the exact location of the 
atoms and how they are connected are known. Hence, it is possible to synthesis 
materials with specific changes in chemical functionalities and matrices.  
 In this way, MOFs have been synthesised for a wide range of applications. These 
materials are utilised in the areas of gas separation, adsorption, catalysis and drug 
delivery,[21] examples include MOF-5, ZIF-8 and ZIF-9.[8] MOFs have been made 
using zinc and sodium for gas adsorption[9] and electrochemical applications.[15] 
Copper based MOFs have been reported as magnetic MOFs.[10] Zinc based MOFs 
such as MOF-5 and MOF-74 have been studied for post-synthesis 
modifications.[11] MOFs such as MIL-101 have been used as catalysts.[12] 
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Manganese based MOFs have been made for hydrogen adsorption.[13,17] IR-MOF-
3 have been used as catalysts.[14] PPF-1 is another zinc based MOF.[16] UIO-68 
has been used for hydrogen storage.[18]  
The above list summarises some interesting applications of MOFs and these 
applications are among the few which inspired the synthesis of a new MOF that 
could be used for potential applications such as drug delivery. In the following 
section some further details of different applications of MOFs are given. 
1.1.1 Applications of MOFs 
Heterogeneous catalysts such as zeolites, porous solids and metal organic 
frameworks have shown potential as solid catalysts.[27] MOFs, in comparison to 
other crystalline structures, can be made with a large variety of metal nodes and 
organic linkers which arises to many different combinations that can be predicted 
and also can be interchanged during post-formation. As the solid catalysts MOFs 
offer additional points of coordination on the metal nodes, and as the linkers can 
be exchanged therefore additional site availability as well as change in porosity 
could be obtained. This in turn favours the use of MOFs alongside established 
inorganic porous materials.[27] 
Several commercially available MOFs were used to demonstrate the potential of 
using premade MOFs in a variety of acid catalysed or aerobic oxidation reactions. 
The MOFs used in such applications included Fe(BTC), Cu3(BTC)2, Al(OH)(BDC) 
and Zn(MeIm)2.
[27] 
Oxidation reactions utilise transition metal compounds as catalysts. The use of 
MOFs in such reactions could minimise the use of toxic transition metals as well 
as reduce the formations of hazardous or toxic waste materials.[27]  
In the studies conducted by Dhakshinamoorthy et al. of the four commercial MOFs 
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Fe(BTC) showed the highest catalytic activity. Current heterogeneous catalysts 
use metals such as Pd, Pt and Au. Using MOFs in the place of heavy metals as 
catalysts will reduce costs and also increase the selectivity of reactions. The key 
points for MOFs awaiting commercialisation are to increase the chemical and 
thermal stabilities such that the productivity of the catalysts can be used in 
industrial processes. Every year more MOF structures are being discovered and 
utilised to assist in various reactions, which previously relied on transition metal 
materials as the main catalyst.[27] 
Porous hybrid inorganic-organic solids/metal organic frameworks show potential 
applications in fields of gas storage, adsorption, separation and catalysis are 
mainly microporous. The smaller size of these micro pores restricts the type of 
materials/drugs that could be used in the field of drug delivery. To overcome this 
shortfall and to produce MOFs with pores of sufficient size for drug delivery of 
different types, Horcajada et al. made chromium-based hybrid solids (MIL-100 and 
MIL-101) using a variety of carboxylic acids. These were used to demonstrate that 
pharmaceutical compounds could be delivered by highly porous network crystals. 
Ibuprofen was adsorbed into the crystals from a solution in hexane and the 
adsorption was determined with techniques such as elemental analysis and x-ray 
fluorescence. Both structures (MIL-100 and MIL-101) showed high adsorption of 
ibuprofen, with different linkers the crystals had varying adsorption values due to 
varying pore sizes.[28]  
The burning of fossil fuels and the resulting atmospheric pollution including the 
release of carbon dioxide into the atmosphere is not desirable. Research into 
MOFs has shown that gas separation and adsorption of gases such as carbon 
dioxide and methane are possible. With the availability to fine tune MOFs, such as 
pore sizes, these materials could be used in tandem with membrane separation 
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techniques. The group of Neves had designed and characterised mixed matrix 
membranes (MMMs) which were made by incorporating porous MOFs into organic 
polymer structures.[29] 
Established MOFs such as MOF-5 and MIL-101 were dispersed into an organic 
solution of Matrimid in various concentrations and then spread as a thin film to dry 
and form the MMMs. The mechanical properties (tension and elongation at break) 
decreased when the concentration of MOF was increased. Although the 
membrane became more rigid with the addition of MOF structures the permeation 
of gases increased. The structures of MOFs can be adapted for the selectivity of 
gases such as carbon dioxide, nitrogen or methane. This has shown that there is 
potential to use MOFs as a part of mixed matrix membranes to separate gaseous 
mixtures.[29] 
Figure 1-3 shows a selection of MOFs which have been used for gas storage. The 
differences in ligands show that a wide variety of structures can be made either by 
changing the shape of a ligand by adding functional groups onto the structure or 
by using larger ligands with an extended network.[30] 
 
Figure 1-3: Examples of MOFs used for gas storage, ranging in shapes and 
sizes dependent on the ligands used.[30] 
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More and more new MOFs with a variety of functionalities have been discovered, 
and researchers are keen to determine effective applications for these materials.  
As advances in the field have been made, chemists have strived to produce 
frameworks which do not generate hazardous bi-products as part of the overall 
synthesis.[25] Every potential new use of MOFs brings the challenge of determining 
a method of using more environmentally friendly materials which may yield the 
same outcome as using bulk stock such as hydrocarbons from crude oil. One way 
this was approached was by using starting chemicals derived from naturally 
occurring materials.[26]  
The limitless possibility of combinations and applications for MOFs makes this 
area very fruitful for research. 
1.2 Cyclodextrin 
Cyclodextrins are cyclic compounds which are made of α-D-glucopyranose 
(glucose) units. It was discovered by the chemist Antoine Villiers in the late 19th 
century.[24] The glucopyranose units are joined together at carbons C1 and C4, 
this is known as α(1-4)-glycosidic bond, shown in figure 1-4. These types of bonds 
form when two or more sugar molecules join with one another by a loss of a water 
molecule at the positions one and four. When multiple sugars are joined together 
these classes of molecules are known as oligosaccharides. The most common 
structures are made of 6, 7 & 8 units, known as alpha (α), beta (β) and gamma (γ)-
















Figure 1-4: General structure of the most abundant cyclodextrins where n = 
1, 2 and 3 are -, - and -cyclodextrin respectively (Left). Glucopyrnose unit 
with carbons highlighted to show the α(1-4)-glycosidic bond (Right).[24] 
The structures of cyclodextrins are cone shaped with two faces. The primary face 
has the hydroxide group bonded to the methyl group (carbon 6) or primary 
carbons. The secondary face has the hydroxide groups bound directly to the 
central ring (carbon 2 and 3), or secondary carbons. When in solution the 
hydroxide groups are arranged such that all the groups point away from the central 
cavity of the cyclodextrin, this forms a hydrophobic environment in the central 
cavity (Figure 1-5).[31] 
 
Figure 1-5: Structure of cyclodextrin showing the 3D orientation of the 
molecule.[31] 
Primary face Secondary face 
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The outer hydroxide groups of cyclodextrin are more easily attracted to polar 
molecules whilst the inner cavity is then able to bind non-polar molecules such as 
hydrocarbons. This ability to bind non-polar compounds when in polar solutions 
has peaked research interest in this class of molecules. 
The primary focus on CDs has been on α-CD and γ-CD due to the structures 
being symmetrical. Functionalised β-CD has seen uses in various industries as the 
additional groups opened more applications which improved upon different areas. 
Some notable examples of the use of functionalised β-CD over unaltered β-CD are 
methyl-β-CD and hydroxypropyl-β-CD.  
Methyl-β-CD has been widely used in biology as an extractor of cholesterol from 
cell membranes, specifically because it forms a strong inclusion complex with 
cholesterol in solution.[23] Hydroxypropyl-β-CD has been used in the food industry 
throughout the world and is considered safe to use.[32] Figure 1-6 shows the 
positions at which CDs are substituted to form functionalised derivatives. In the 
case of methyl-CD the R groups are either hydrogen (H-) or CH3 group and for 
hydroxypropyl-CD the R groups are either H- or CH2CHOHCH3 group. 
 
Figure 1-6: Structure of cyclodextrin showing the positions of substitution (R 
groups).[32] 
1.2.1 CD-MOFs and applications 
Recently a study was reported where γ-CD was used to make a new MOF which 
was biodegradable.[25,26] This was done by using food-grade materials (γ-CD and 
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KOH) in a vapour diffusion experiment. Vapour diffusion was achieved by mixing a 
ratio of 1:8 mmol of γ-CD and KOH in water then allowing slow diffusion of 
Everclear grain spirit (ethanol) over a few days. 
The resulting structure was a highly porous, extended body-centred cubic 
crystalline material named CD-MOF-1. The primary face of γ-CD formed the inner 
face whilst the secondary face made up the outward face of the cube (Figure 1-7). 
The crystal structure revealed that each of the potassium (K) ions was coordinated 
to four γ-CD rings through four different glucopyranose units. Two of the 
glucopyranose units were coordinated through the secondary hydroxide groups 
whilst the other two units were coordinated through the glycosidic ring oxygen and 
the primary hydroxide group. 
Another metal salt, rubidium hydroxide, was also used in a ratio of 1:8 with γ-CD 
as above.[25,26] The structure formed was also an extended body-centred cubic 
network and named CD-MOF-2. These γ-CD crystals share the same crystal 
structure but are different due to the use of different metals which link the CD units 
together. Figure 1-7 shows the cubic structure of CD-MOF-1 and CD-MOF-2. 
 
Figure 1-7: Structure shared by CD-MOF-1/CD-MOF-2 shown as a space 
filling representation of the body-centred cubic network.[25,26] 
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For modern drug delivery technologies increasing or enhancing the solubility and 
bioavailability of active pharmaceutical ingredients (APIs) has been desirable 
because a large number of potential compounds are hydrophobic. The central ring 
of CD forms hydrophobic cavities, as mentioned earlier. As CDs can form inclusion 
complexes which can shield hydrophobic structures in hydrophilic media, this 
feature makes CDs a good candidate as a material which can be used to enhance 
water solubility of hydrophobic APIs.[33] 
Ibuprofen is used to treat inflammation in cells and also for possible cancers. This 
had already been entrapped in other MOFs such as UiO-66, however due to the 
toxic nature of the metals/linkers present in the structures it was not possible to 
carry out tests in vivo (in living tissue). CDs are considered to be safe to use (in 
edible products) and γ-CD can be hydrolysed by salivary α-amylase,[33] CD-MOFs 
could be used as part of new potential rapid drug delivery by oral ingestion.[33] 
Two methods were used to study the uptake of ibuprofen: co-crystallisation and 
absorption. In both methods a racemic mixture of the (S)-(+) enantiomer 
(pharmaceutically active) and (R)-(-) enantiomer (pharmaceutically inactive and 
non-toxic) of ibuprofen was used. Further tests showed that CD-MOF-1 was not 
selective towards either enantiomer and uptakes of both were seen. An advantage 
of ibuprofen is that the non-toxic (R)-(-) enantiomer can be metabolised to form the 
other active enantiomer by a unidirectional chiral inversion.[33] 
CD-MOF-1 has the potential to be utilised as an effective oral drug delivery media 
for pharmaceutical ingredients which are hydrophobic in nature. With ibuprofen it 
was shown that CD-MOF-1 could be prepared using potassium derivatives or even 
soaked in free acid forms and both methods showed positive results towards a 
rapid uptake/delivery mechanism.[33] 
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The porous structure CD-MOF-2 was found to be highly selective for the 
adsorption of carbon dioxide (CO2) at low pressures.
[34] The method by which CO2 
is captured in CD-MOF-2 is by reaction of the CO2 molecules with free hydroxide 
groups to form carbonic acid. The process was found to be reversible. Favourable 
reactivity arises in CD-MOF-2 as γ-CD had many accessible hydroxyl groups at 
the circumference of the large pores (1.7 nm diameter). If the binding of carbon 
dioxide occurred by the formation of a carbonate ester (reaction of an OH group 
on CD with a CO2 molecule), then it could be possible to view gaseous uptake by 
diffusing a readily available pH indicator.  
The compound methyl red was diffused into the CD-MOF-2 network and when 
dried, formed yellow crystals due to deprotonation (anion metathesis). When 
exposed to any source of carbon dioxide the crystals changed colour to 
orange/red which showed a positive result for carbon dioxide. The crystals were 
cycled several times and did not show apparent fatigue. The uptake was only 
observed when the network was in a solid-crystalline state, as when the crystals 
were crushed no colour change was observed in the presence of carbon dioxide. 
The ability for the crystal to capture carbon dioxide and that it can also be re-used 
multiple times (along with small coloured indicators) revealed that environmentally 
benign materials could be effectively used as a source of carbon fixation.[34] 
The biocompatibility of materials is essential for applications of MOFs in biological 
systems. Metals such as Ca, Fe, Zn, Ti and K are considered as biologically 
acceptable [35] established by their oral lethal dose LD50 which is a single dose of a 
substance that causes the death of 50% of an animal population from exposure to 
that substance by any route other than inhalation. Therefore, interest has been 
growing to use biomolecules as linkers suitable to link together those metals in 
biologically active MOFs. Naturally occurring materials such as peptides, 
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carbohydrates, amino acids and a variety of compounds have been reported as 
being suitable to link together metal ions to form functional porous frameworks. 
One such example is the synthesis of environmentally friendly and renewable CD-
MOFs obtained from γ-CD and K cations using -OCCO- linker which were used in 
drug absorption applications.[35] 
Very few studies have focused on the hydrothermal, chemical and thermal 
stabilities of MOFs and CDMOFs when molecules such as various drugs are 
adsorbed into the framework.[35] 
CD-MOFs are potential candidates in drug absorption applications. Liu et al. 
(2016) investigated absorption behaviour of 21 different drugs to γ-CD-MOF. 
Synthesis of CD-MOF was carried out by changing variables such as reactant 
concentrations and time and the crystalline stability was studied for different 
temperatures, solvents and humidity. It was demonstrated that drugs which had 
carboxyl groups present in them showed higher adsorption whereas drugs with 
nitrogen and other heterocyclic rings showed low adsorption.[35] 
The unaltered form of β-CD has seen very little use in chemistry in contrast to 
functionalised β-CD because of weaker binding of molecules. Therefore this 
project will aim to show that unaltered β-CD can be used to effectively to form 
coordinate networks which will be able to replicate or come close to being similar 





MOFs have been established as effective materials for drug delivery, such as 
chromium MOFs[28] and CD-MOFs[33] were used to bind ibuprofen.[33] Vesicles are 
also widely used in drug delivery[36] with the advantage that they can protect the 
inner contents from external environments. This feature has widely been utilised in 
drug delivery for treating cancers.  
Vesicles are phospholipid bilayer capsules which can resemble the membranes of 
cells. Cell membranes are made of three main components: lipids including 
phospholipids and cholesterol, proteins, and carbohydrates as described in the 
fluid mosaic model of cell membranes.[37,38] 
Phospholipids are a main part of cell membranes as the structure contains a 
phosphate group as a ‘head’ and this is connected to two fatty acid hydrocarbon 
tails. A bilayer is formed when two rows of phospholipids arrange so that the 
phosphate heads point outwards towards solvent, such as water, and the fatty acid 
hydrocarbons forms a middle layer (Figure 1-8, the idea was taken from the 3D 
model by Nicolson, 2014).[38] 
 
Figure 1-8: 2D schematic representation of phospholipid bi-layer where the 
phosphate groups (dark circles) point towards outer and inner solvent and 
the lipid tails form the inner (nonpolar) section of a cell membrane. Proteins 
are distributed throughout the membrane shown here as elliptical shapes. 
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Cholesterol is a crucial part of animal cells as this molecule helps to keep the cell 
membrane in a fluid state. The presence of cholesterol reduced the disorder in the 
lipid tails; this in turn caused the lipid tails to arrange equally throughout the bilayer 
membrane as shown in figure 1-9.[39]  
 
Figure 1-9: Molecular dynamics simulation of (A) DOPC only bilayer and (C) 
2:1 ratio DOPC/cholesterol bilayer with terminal methyl groups as purple and 
magenta, acyl chains as grey and cholesterol shown as gold. (B) and (D) 
show the distribution of terminal methyl groups in respective bilayers.[39] 
It was also observed that cholesterol in the presence of high-melting lipids (gel 
phase) and low-melting lipids (liquid-disordered ld phase) causes a fluidising effect 
to the former and a condensing effect to the latter. This in turn brings the different 
lipids to an intermediate stage (liquid-ordered lo phase) where the thickness, 




Figure 1-10: A general representation of the effects of cholesterol of low and 
high melting lipids.[40] 
Unilamellar (single bilayer) vesicles are typically categorised into three main types 
by diameter, small <50 nm (SUVs), large <100 nm (LUVs) and giant >100 nm 
(GUVs). These have been used in a wide variety of applications such as studies of 
membrane protein interactions and lipid domain characteristics.[41] GUVs have 
been primarily used as cell mimicking models as the size of around 10µm, 
membrane curvature and phospholipid content can be made to be almost similar 
to animal cells.[42] The similarities to animal cells have led to a wide variety of 
studies in which GUVs have been used to simulate models of membrane 
interactions as well as effects of content and shape of vesicles in the presence of 
certain drugs or specific proteins. 
Figure 1-11 shows various vesicles made from membrane lipid extracts as well as 
mixtures of lipids with and without cholesterol. The scale bars represent 10 µm. A 
fluorescence tagged molecule is typically incorporated into lipid mixtures to view 




Figure 1-11: Fluorescence images of vesicles made using electroformation 
A) Vesicles made using red blood cell membrane lipid extracts B) Vesicles 
made from lipids and 20 mol% cholesterol and C) Vesicles made from lipids 
only without cholesterol. The scale bars shown represents 10 µm.[43] 
A fluorescent derivative known as topfluor cholesterol (cholesterol with the 
hydrocarbon chain replaced by BODIPY group)[44] is also used to view vesicles 
(under blue light excitation). These help to distinguish a vesicle from surrounding 
medium. The bodipy group is a fluorophore component of the molecule which is 
hydrophobic and insensitive to changes in conditions such as polarity and pH. The 


































There are many different methods to synthesise vesicles, dependent on the 
required size. The most typical methods are electroformation and extrusion.  
The method of extrusion involves compressing a mixture of suspended lipids in a 
buffer solution through a series of fine filters and polycarbonate membranes using 
a pair of gas-tight syringes and a mini-extruder device. This is a long process and 
yields vesicles which have high sample reproducibility. Overall extrusion is a 
relatively slow process and requires manual handling of components.[45] 
Electroformation involves applying an alternating current through a lipid solution 
suspended in an ionic buffer solution. There are various ways to perform this 
process. Indium Tin Oxide (ITO) coated slides with spacers have been used to 
form wells in which suspensions can be held and electrodes have been used 
directly placed in solutions as a surface for vesicle formation. This is a relatively 
fast process and yields vesicles with varying sizes. This method is favoured for 
producing GUVs since only a few components (current source, circuit and 
suspension well/vessel) are needed to obtain vesicles in a short time.[46]  
One aspect which has yet to be shown is the merging or encapsulation of MOFs 
with in vesicles (rather than on to the vesicle membranes) to make a single 
biocompatible system which could potentially be used as a rapid delivery system 




1.4 Project Aims 
This project aims to investigate the uptake of sterols by a new β-CD porous 
network. If cholesterol, or structures of similar importance such as hormones or 
medicinal compounds, can successfully be bounded to a new porous β-CD 
network, or if MOF crystals could be encapsulated within vesicles then this could 
open up a new field of research in solid state chemistry. If successful, this could 
lead to the utilisation of solid-state materials within biological systems including but 
not limited to, transport of essential materials, removal of toxins or hazards, direct-
to-cell drug delivery, specific cell to cell interactions, direct-to-cell cancer therapies, 
etc. 
In this project new frameworks of β-CD with potassium were synthesised and 
analysed using different analytical tools and techniques such as X-ray diffraction, 




All chemicals and solvents were purchased from Alfa Aesar, Fisher Scientific, 
Sigma-Aldrich, Cambridge Isotope Laboratory and Avanti Polar Lipids and used 
without further purification unless stated otherwise. 
Powder X-Ray Diffraction (PXRD): PXRD measurements were carried out at 298 
K using a Rigaku benchtop X-ray diffractometer (λ (CuKα) = 1.5405 Å) on a zero-
background holder. Data were collected over the range 3–45°. (University of Kent) 
Single Crystal X-Ray Diffraction (SCXRD): A suitable crystal of each compound 
was selected and mounted on a Rigaku Oxford Diffraction Supernova 
diffractometer. Data were collected using Cu Kα radiation to a maximum resolution 
of 0.84 Å. Each crystal was kept at 100(1) K during data collection using an Oxford 
Cryosystems 800-series Cryostream. The structures were solved with the 
ShelXT[47] structure solution program using Direct Methods and refined with 
ShelXL[48] via Least Squares minimisation. Olex2[49] was used as an interface to all 
ShelX programs. The data was collected and solved by Dr Shepherd (Tables 2-4). 
Thermal Gravimetric Analysis (TGA): Measurements were carried out using a 
NETZSCH STA 409 PC/PG apparatus. Measurements were collected from room 
temperature to 450 °C with a heating rate of 10 °C/min under an air atmosphere. 
(University of Kent) 
Nuclear Magnetic Resonance Spectroscopy (NMR): NMR spectra were 
recorded on a JOEL NMR 400 MHz spectrometer and referenced to residual 
solvent peaks. (University of Kent) 
Fluorescence Imaging: Fluorescent images were recorded on Etaluma 
Lumascope 620 digital microscope. The blue LED excitation was a wavelength 
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range of 473-491 nm and emission wavelength was in the region of 502-561 nm. 
(University of Kent) 
Scanning Electron Microscopy (SEM): SEM images were recorded on a Hitachi 
S3400 SEM. The electron beam was set to 20 kV. Back scatter and secondary 
electron images were captured using inca software. (University of Kent) 
2.1 Crystal Synthesis 
2.1.1 KβCD-MOF-1 
The method used to make edible MOFs (Smaldone et al.)[25] was adapted to be 
used for β-cyclodextrin in place of γ-cyclodextrin. The scale of the process was 
adjusted to be compatible with available glassware in the laboratory. 
β-cyclodextrin (0.5675 g, 0.5 mmol) and potassium hydroxide (KOH) (0.5610 g, 10 
mmol) was added to a 10 mL volumetric flask and dissolved in de-ionised water 
(10 mL). Then 1 mL of this mixture was added to a 2 mL borosilicate sample vial. 
The 2 mL sample vial was placed in a 14 mL sample vial which contained 2.5 mL 
methanol. This system was sealed with a cap and set aside for crystal formation 
over a period of 6-7 days. This was repeated a further nine times to obtain ten 
samples in total. To perform post synthesis analysis, crystals were carefully 
washed with 2 × 1 mL of ethanol. Elemental analysis for C168H295O152K9 
(4βCD9KOH4H2O) calc: C: 39.43, H: 5.85, N: 0.0; found: C: 39.59, H: 5.69, N: 
0.0. 
2.1.2 KβCD-MOF-1-Chol 
A stock solution of β-cyclodextrin (0.5675 g, 0.5 mmol) was made in de-ionised 
water (10 mL). Potassium hydroxide (0.1122 g, 2 mmol) was weighed into a 2 mL 
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borosilicate vial and 2 mL of the β-CD stock solution was added (forming the 
KβCD-MOF-1 aqueous mixture). Then 1 mL of this mixture was added to an NMR 
tube. Deionised water of 0.1 mL was added followed by 0.1 mL methanol to the 
mixture in the tube. Cholesterol (0.0128 g, 0.033 mmol) was added to 2 mL 
methanol and then 1 mL of this solution was carefully added to each of the NMR 
tubes. The tubes were sealed with a cap and set aside for crystal formation for 2-3 
weeks. 
2.1.3 β-Cyclodextrin control crystals 
β-cyclodextrin (0.5675 g, 0.5 mmol) was dissolved in 10 mL of de-ionised water in 
a 10 mL volumetric flask. 1 mL of this solution was added to a 2 mL sample vial 
then the smaller 2 mL sample vial was placed in a larger 14 mL sample vial which 
contained 2.5 mL methanol. This system was sealed with a cap and set aside for 
crystal formation over a period of 1-2 days. 
2.1.4 KβCD-MOF-2 
Potassium benzoate (0.0080 g, 0.05 mmol) was weighed into a 2 mL sample vial 
and this was used in the place of potassium hydroxide (which was used to make 
KβCD-MOF-1 in section 2.1.1.) in a 1:1 mol ratio with β-cyclodextrin. Then 1 mL of 
β-CD solution (0.5675 g, 0.5 mmol in a 10 mL solution) was added to the 2 mL 
vial. The 2 mL sample vial was placed in a 14 mL sample vial which contained 2.5 
mL methanol. This system was sealed with a cap and set aside for crystal 




2.2 Sterol Uptake by New β-CD Network 
2.2.1 Sterol uptake and Proton NMR study 
A stock solution of cholesterol (0.005 M) was made in ethanol; 2 mL was added to 
some crystals to see if any changes occurred. The control β-CD was also used as 
a comparison. Proton (1H) NMR was used to determine the ratio of β-cyclodextrin 
to bound cholesterol (in the crystal).  
The solvents used for NMR analysis were deuterated dimethyl sulfoxide-d6 
(DMSO-d6) and deuterated methanol-d4 (MeOD) from Cambridge Isotope 
Laboratory. The ratios of solvents used for analysis of all the crystal samples (pure 
and soaked with sterols) were 750 µL of DMSO-d6 with 100 µL of MeOD. 
Three other sterol compounds, β-estradiol, testosterone and deoxycholic acid 
were also used to investigate the uptake of the new KβCD-MOF-1. The sterol 
structures are shown in Figure 2-1. The ratios of solvents used for analysis of pure 
sterols were 750 µL of DMSO-d6 with 10 µL of MeOD. 
 
Figure 2-1: Structures of Cholesterol and other sterols used in this study 
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2.2.2 Imaging KβCD-MOF-1 soaked in topfluor cholesterol 
A topfluor cholesterol solution was prepared by placing 50 µL of a 1mg/mL stock 
solution (Avanti polar lipids) into a 2 mL borosilicate sample vial. The chloroform 
was removed by drying the topfluor cholesterol under argon gas. Then 2 mL of 
ethanol was added to form a topfluor solution with a concentration 25 µg/mL. 
Next the crystal samples of KβCD-MOF-1 were washed twice with 1 mL ethanol 
and then were transferred to a 10 mm microwell (35 mm diameter) petri dish. 
The topfluor solution was carefully transferred to this petri dish and the dish was 
sealed with parafilm and set aside for duration of 24 hours. 
After 24 hours, the parafilm was removed and the topfluor solution was extracted 
carefully. Then the crystal samples were immediately washed twice with 1 mL of 
ethanol and then 2 mL of ethanol was added to the petri dish for imaging the 
crystals in bright field and blue light excitation under an Etaluma Lumascope 620 




2.3 Giant Unilamellar Vesicles 
Giant unilamellar vesicle formation protocol was performed as described in 
Rossman et al., Cell 2010.[50] 
A lipid mixture was prepared by taking 40 µL of a 25 mg/mL stock solution of the 
lipid 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine, DMPC (Avanti Polar 
Lipids), and 0.1 mol% TopFluor Cholesterol (Avanti Polar Lipids) was incorporated 
to form a mixture with concentration of 1 mg/mL in 1 mL chloroform.  
Next the resistance across two indium-tin oxide coated slides (Delta Tech #CG-
90IN-0115, 70-100Ω) surfaces were measured to determine which side of the slide 
was conducting. The uncoated side = large resistance reading (>1 MΩ), coated 
(conducting) side = small resistance (<1 kΩ). 
A 9 mm Fastwell (Grace Bio, #664112) was placed on the edge of the slide on the 
non-conducting surface and a circular well area was marked, and then 6.5 µL of 
the lipid mixture was deposited onto the conductive side of an ITO coated slide 
(and repeated with a second slide). 
The slides were dried in a vacuum chamber to drive off any excess chloroform (1-
2 hours). To one of the slides a Fatwell spacer was placed over the lipid area to 
form a well and to this well 70 µL of an electroformation buffer (0.1 M sucrose, 1 
mM HEPES) was added. The second slide was positioned, slightly offset, with the 
conductive side and lipids towards the spacer. The well was sealed by pressing 
both slides together as shown in figure 2-2. Copper taping was applied to the 
conductive side of the ITO slide and was used to form a complete circuit to a GW 






Figure 2-2: A) lipids (green) are thinly coated onto ITO slides, B) A pair of 
ITO slides are placed together with a fastwell spacer (red) with buffer to re-
suspend lipids, C) copper tape (orange) is applied to the exposed 
conductive side of the ITO slides to be connected to a circuit with a function 
generator. 
The GW Instek SGF-1013 generator was set to a sine wave of 10 Hz at 1.00 V for 
4 hours and the slides were placed in a dark environment. After the 4 hours the 
circuit was dismantled and the slides were carefully taken apart. Approximately 60 
µL of the samples (per pair of slides) was recovered using a wide bore pipette and 
added to an Eppendorf tube which contained 540 µL of a resuspension buffer (0.1 
M glucose, 1 mM HEPES). About an hour before the electroformation was 
completed a Nunc Lab-Tek II chamber slide was opened and the wells were 
blocked with 5 % milk solution for an hour then this was washed with 3x phosphate 
buffered saline (PBS). 
To view the vesicles approximately 200 µL of the re-suspended lipid mixture was 
carefully placed into the Nunc Lab-Tek II chamber slide wells. The chamber slide 
was placed onto an Etaluma Lumascope 620 fluorescence microscope and 




3. Results and Discussions 
3.1 Cyclodextrin crystals 
Cyclodextrins can easily form inclusion complexes with a variety of compounds 
and has been used in a wide range of applications in industry. More recently it has 
been demonstrated that cyclodextrins can be used to form biodegradable 
crystalline structures which themselves are able to form inclusion complexes.[25] 
3.1.1 KβCD-MOF-1 network 
MOF crystals were synthesised according to the vapour diffusion method outlined 
in section 2.1.1. The crystals were long ‘needle-like’ and white in colour. This new 
structure was named KβCD-MOF-1. The results from single crystal X-ray 
diffraction showed β-cyclodextrin channels which were perpendicularly stacked in 
layers with β-CD being held in place in the lattice by potassium (K) within the 
complex as shown in figure 3-1. 
Also it was seen that the β-CD were arranged in primary to primary and secondary 
to secondary faces in the channel. The structure of CD-MOF-1 formed a cubic 
network with the secondary face forming the outer layers of the structure. The 
structure of CD-MOF-1 used a ratio of 8:1 K:γ-CD, this new KβCD-MOF-1 network 





Figure 3-1: SC-XRD derived structure of KβCD-MOF-1, where white is 
carbon, red is oxygen and purple is potassium. 
A previous structure incorporating β-CD, KOH and water was published in 1991 by 
Charpin et al.[51] The ratio they used to obtain a crystal was 1:1:8 of β-




Figure 3-2: The herring bone scheme of the 1:1:8 β-CD:KOH:H2O structure 
observed by Charpin et al.[51] 
The structure they obtained was of cyclodextrins stacked in a herringbone scheme 
with potassium in between the lattice. Comparing the new KβCD-MOF-1 to the 
herringbone scheme, the similar features are that the new structure lattice is made 
of β-CD with potassium throughout the lattice holding the structure together. 
Where the structure by Charpin et al. had cyclodextrin stacked in an offset position 
(the cavities are not accessible), the new KβCD-MOF-1 was made of cyclodextrin 
channels (similar to nanotubes) stacked in perpendicular layers so all of the β-CD 
in KβCD-MOF-1 is fully accessible. 
Another structure of β-CD was published in 1996 by Nicolis et al.[52] This structure 




Figure 3-3: The herring bone scheme of the 1:2:11.25 βCD:CaCl2:H2O 
structure observed by Nicolis et al.[52] 
Nicolis et al.[52] obtained a herringbone structure with both the calcium and chloride 
ions along with water molecules holding the lattice together crosslinking the 
cyclodextrin molecules. Therefore, with only water present as the main solvent the 
herringbone arrangement is the most stable for β-CD in a lattice. Unlike the 
structures observed by β-CD in water with KOH or CaCl2 the new KβCD-MOF-1 
was made in a water/methanol environment with a higher ratio of available 
potassium ions in solution. 
CD-MOF-1 and CD-MOF-2 were made using exact ratio of available bonding site 
of γ-CD to potassium metal.[25,26] The vapour diffusion recrystallisation method 
used to synthesise γ-CD MOFs was adapted for β-CD and, in this project, the ratio 
of potassium metal was in excess to the number of available bonding sites per β-
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CD molecule in a ratio of 20:1 potassium:β-CD. Upon recrystallisation by vapour 
diffusion, the 20:1 potassium:β-CD mixture produced a new crystal structure. 
The lattice parameters for the new KβCD-MOF-1 crystal were a = 15.26(929) Å, b 
= 15.29(258) Å and c = 29.74(094) Å, α = 100.60(9)°, β = 94.36° and γ = 
95.22(8)°. The spacegroup is Triclinic P1 (no. 1). The unit cell for KβCD-MOF-1 is 
K9CD4. 
When the parameters were searched in CCDC database there were no other 
crystal structures with the above identity.  
Thus, a new crystal network was identified using β-CD and potassium hydroxide. 
3.1.2 β-Cyclodextrin control crystals 
After the new β–CD networks were made and the method was established, a 
comparison was sought after to show that these structures were unique. Therefore 
vapour diffusion was carried out with only β-CD in water with methanol to see what 
would happen without the presence of any metals or other ions in solution. 
When β-cyclodextrin was left to crystallise on its own, the large cubic crystals 
formed. These cubic crystals were analysed using SC-XRD (figure 3-4), showing 
that arrangement of β-CD a zipper, i.e. the β-CD cavities were blocked due to a 




Figure 3-4: SC-XRD derived structure of control β-CD crystal, where white is 
carbon and red is oxygen. 
Lattice parameters were a = 15.14(75) Å, b = 10.03(24) Å and c = 20.98(65) Å, β = 
110.96°. The spacegroup was Monoclinic P21 (no. 4). The control crystals were 
held together by intramolecular forces between the cyclodextrin molecules such as 
hydrogen bonding between oxygen and hydrogen in the structures. The structure 
in figure 3-4 is similar to the herringbone structure by Charpin et al.[51] and Nicolis 
et al.[52] as the offset staggered arrangement of β-CD matches the herringbone 
scheme previously reported. Unlike those structures where the metal salts and 
water were present in between the cyclodextrin molecules, the control crystals 
formed in this project were made only in a mixture of water and methanol. This 
offset arrangement of β-CD means that beyond the outer layer of cyclodextrin the 
inner β-CD would not be accessible. 
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3.1.3 KβCD-MOF-2 network 
Following the discovery of the β-CD KOH networks a different potassium salt 
(potassium benzoate) was used to see if that would have any effect on the crystal 
formation. Very fine small white coloured crystals were obtained from vapour 
diffusion. Figure 3-5 shows the structure of the CD-benzoate crystal analysed 
using single crystal X-ray diffraction. These crystals showed a 2D network of β-CD 
channels which were connected by potassium. Lattice parameters of KβCD-MOF-
2 were a = 14.89(066) Å, b = 15.62(972) Å and c = 15.70(794) Å, α = 90.18°, β = 
104.23(1)° and γ = 104.12(2)°. The spacegroup was P1 (no. 1). 
 
Figure 3-5: SC-XRD derived structure of KβCD-MOF-2 network, where white 





Within the pores of cyclodextrin, benzoate molecules were observed. Similarly to 
KβCD-MOF-1, the arrangements of β-CD molecules in this structure were primary 
face, secondary face, secondary face, primary face. 
This structure was found to be similar to the benzoate inclusion complex with ratio 
of 2:2:0.7:20.65 β-CD:benzoic acid:ethanol:H2O inclusion complex made by 
Thammarat Aree and Narongsak Chaichit, who also had a P1 spacegroup.[53] 
They had obtained a lattice parameter of a = 15.210(1) Å, b = 15.678(1) Å and c = 
15.687(1) Å, α = 89.13(1)°, β = 74.64(1)° and γ = 76.40(1)°. The crystal packing 
image is shown in figure 3-6. The main difference other than size was the angles 
determined for KβCD-MOF-2 was much greater than the inclusion complex alone. 
 
Figure 3-6: The crystal packing image of the 2:2:0.7:20.65 





The other difference between KβCD-MOF-2 and βCD-benzoate complex was that 
the inclusion complex was made by solvent evaporation in a water/ethanol mixture 
(after being heater to 60°C for one hour), whereas the KβCD-MOF-2 network was 
made by the vapour diffusion of methanol into an aqueous solution of β-CD and 
potassium benzoate at room temperature. As with the findings of Aree and 
Chaichit,[53] the benzoate molecules found in the central cavities of β-CD in KβCD-
MOF-2 are also arranged so that the OH group points towards the primary face 
(shorter end of the cone). Three benzoate molecules are present in KβCD-MOF-2, 
these are shown in figure 3-5. The first and third benzoate molecules can be seen 
in the middle of the cyclodextrin cavities whist the second benzoate molecule is 
found parallel to the secondary face of β-CD. As benzoate molecules were 
observed within the cavities of the β-CD in this structure this showed that the β-CD 
of KβCD-MOF-2 are similarly accessible just like KβCD-MOF-1 network. 
3.1.4 KβCD-MOF-1-Chol 
The compound β-CD is in use today as a modulator of cholesterol concentration 
as described in section 1.3. Following the discovery of the KβCD-MOF-1 network 
by vapour diffusion, cholesterol was added to the crystallisation mixture of solvent 
diffusion to see if that would have any effect on the crystal formation of the KβCD-
MOF-1 mixture. Figure 3-7 shows the structure of the β-CD-KOH-cholesterol 
crystal analysed using single crystal X-ray diffraction. This crystal showed a 2D 
network of β-CD channels which formed a honeycomb like structure which was 




Figure 3-7: SC-XRD derived structure of KβCD-MOF-1-Chol network, where 
white is carbon, red is oxygen and purple is potassium. 
On further analysis of KβCD-MOF-1-chol SC-XRD, it was found that cholesterol 
had partial occupancy of cyclodextrin (1 cholesterol molecule was observed for 
every 6 β-CD molecules in the lattice). The aliphatic chain (of cholesterol) was 
omitted from the SC-XRD image above due to a high degree of disorder in that 
part of the molecule. Comparing the crystal structures of KβCD-MOF-1 and that of 
KβCD-MOF-1-Chol the similarities are both used the same quantities of β-CD and 
KOH. The addition of cholesterol into methanol using solvent diffusion method 
formed a honeycomb like network rather than a series of perpendicular layered 
channels which were formed during vapour diffusion. The β-CD channels formed 
in KβCD-MOF-1-Chol similarly to KβCD-MOF-1 and KβCD-MOF-2 are accessible 
and here it was observed that cholesterol can be held within the β-CD cavity of this 
structure. 
3.2 Powder X-ray Diffraction 
Powder X-ray diffraction (PXRD) was used to initially assess the structure of bulk 
samples of the KβCD-MOF-1 network. PXRD is an analytical technique which can 
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provide information on the unit cell dimensions of a crystal and this is also a rapid 
technique to obtain the phase identification of a crystal sample, as in the name the 
sample is typically crushed into a fine powder before being placed in a 
diffractometer for analysis. 
 
Figure 3-8: PXRD comparison of the KβCD-MOF-1 crystals, theoretical 
pattern from SC-XRD (bottom), initial experimental result (blue), KβCD-MOF-
1 dried in vacuum (red) and KβCD-MOF-1 dried in air (top). 
Figure 3-8 shows the PXRD patterns obtained for KβCD-MOF-1 experimentally 
and a predicted model which was based on the SCXRD structure of KβCD-MOF-1 
crystal. Broad intensities (peaks) were observed in the experimental crystal 
patterns at values of 2θ at 6°, 11.5°, 13.5°, 17.5° and 18.2°. The positions of these 
peaks did match with the peaks in the predicted pattern. There were suggestions 
of peaks between 6-11° and 14-17° in the experimental patterns compared to the 
predicted pattern; however these could not be identified. Particle size is inversely 
proportional to peak width observed in XRD patterns.[54] Therefore the broadening 
seen in the experimental patterns could be due to small particles already present 
or which were formed when crystal samples were prepared for PXRD. 
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3.3 Cholesterol Uptake By New β-CD Network 
The crystal structure of the KβCD-MOF-1 network showed continuous channels 
which closely resembled carbon nanotubes. β-cyclodextrin is known to effectively 
bind nonpolar molecules and methyl-β-CD has been shown to bind cholesterol. 
 
Figure 3-9: Images of KβCD-MOF-1 crystal before (A) and after (B) soaking in 
cholesterol solution, and images of β-CD crystal before (C) and after (D) 
soaking in cholesterol solution. The scale bar for A and B are 10 µm at 40x 
magnification and for C and D are 100 µm at 10x magnification. 
It was decided to see if any interactions would occur between cholesterol in 
solution with the newly formed KβCD-MOF-1 network. Initially a stock solution of 
cholesterol (0.005 M) was made in ethanol; 2 mL was added to some crystals 
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(which were washed twice with 1 mL ethanol) to see if any changes occurred to 
the crystal morphology. The control β-CD was also used as a comparison. 
The results showed that after an overnight soaking the morphology of the KβCD-
MOF-1 ‘nanotube network’ crystals remained unchanged before and after soaking, 
this can be seen on bottom right hand side of figure 3-9 A and B. On the other 
hand the control crystal had additional crystal growth on the edges of the crystal 
after soaking, shown in figure 3-9 C and D, this was due to nucleation of 
cholesterol due to the inaccessibility to the cyclodextrin cavities in inner parts of 
the control crystal. 
This showed the new KβCD-MOF-1 network was capable of up taking cholesterol 
without changing morphology. Therefore, KβCD-MOF-1 network could be used as 
a possible storage medium or adsorption medium for compounds such as 
cholesterol which plays a key role in the fluidity of cell membranes as described in 
section 1.4. 
3.3.1 Uptake ratio determination using Proton NMR 
In order to obtain a quantitative measurement proton (1H) NMR was used to 
analyse the ratio of cyclodextrin to cholesterol up taken after soaking a sample of 
crystals in a known concentration of cholesterol (2 mL of 0.01 M) solution for 24 
hours. The ratio was determined by using the integration of known distinctive 




Figure 3-10: NMR Spectrum of cholesterol (top), KβCD-MOF-1 soaked with 
cholesterol (middle) and KβCD-MOF-1 crystal (bottom). 
In order to compare the ratio of cyclodextrin to sterol present in the crystals certain 
peaks were chosen that were unique to respective molecule which would not 
overlap with the other structure. For β-cyclodextrin this was the glycosidic proton, 
since each β-CD molecule has a total of 7 glycosidic protons, the chemical shift 
occurred at 4.8 ppm.[55] In each case for individual sterols the pure spectra were 
compared to β-CD and peaks were chosen which could be distinguished as the 
sterols. For cholesterol the isopropyl group, at 0.8 ppm (1’) shown in figure 3-10, 
was chosen as it was known that the signal was due to the presence of 6 
protons[56] therefore, by setting the integration at 0.8 ppm to 6, the ratio of β-CD to 
cholesterol was determined. The ratio was 13.92:6, i.e. 14:6, hence for every 
cholesterol molecule there were 2 molecules of cyclodextrin. In the KβCD-MOF-1-























a ratio of 1 cholesterol to 6 cyclodextrin molecules and here similarly for every 2 β-
CD, 1 cholesterol molecule was present. 
3.3.2 Sterol uptake by new β-CD network 
Three other sterol compounds, β-estradiol, testosterone and deoxycholic acid 
were also used to investigate the capability of the new KβCD-MOF-1 network. All 
three compounds shared the similarity of the sterol skeleton, however differed in 
the functional groups present in the structure as shown in figure 3-11. 
 
Figure 3-11: Structures of cholesterol and other sterols used in this study. 
To see if any binding occurred between the KβCD-MOF-1 crystal and the other 
sterols, 1H NMR was again used to analyse the ratio of cyclodextrin to sterol up 
taken after soaking a sample of crystals in a known concentration (2 mL of 0.01 M) 





Figure 3-12: NMR Spectrum of testosterone (top), KβCD-MOF-1 soaked with 
testosterone (middle) and KβCD-MOF-1 crystal (bottom).  
Similarly to cholesterol, for testosterone a proton environment was chosen which 
was unique to this structure shown in figure 3-12. The proton adjacent to the 
ketone group bonded to the unsaturated carbon (2’).[57] This was given integration 
of 1 at 5.7 ppm and then the glycosidic proton integration was determined. The 
ratio was 1:26.6 i.e. 1:27 which approximates to one testosterone to four 
cyclodextrin molecules. The peaks in the region of 3.0-3.75 ppm were broad due 
to high abundance of protons which could not be distinguished. The peaks for 
testosterone in the region of 0.5-2.5 ppm were not seen in the spectra of the 
mixture; this could have due to the protons of the testosterone hydrogen bonding 
to cyclodextrin cavity and hence be shielded. The peaks at 5.75 ppm in the crystal 
spectra were not present in the composite spectra as these were due to the 



























Figure 3-13: NMR Spectrum of beta-estradiol (top), KβCD-MOF-1 soaked with 
β-estradiol (middle) and KβCD-MOF-1 crystal (bottom).  
Compared to the other sterols used in this study β-estradiol contained an aromatic 
tri-substituted benzene in the structure (1’, 2’ and 4’) shown in figure 3-13. 
Therefore, these unique protons were used to compare to β-CD which had no 
aromatic groups in the molecule. The chemical shifts of the aromatic protons 
occurred in the range of 5.98, 6.05, 6.70 ppm.[58] Hence as each of the aromatic 
protons produced integration of one, these sets of peaks were used as a 
comparison to β-CD. The ratio of β-CD to β-estradiol in figure 3-13 was 13.88:1, 
i.e. 14:1. For every one β-estradiol molecule there were 2 cyclodextrin molecules 
present. The down field shift of the aromatic protons in the composite spectra 
could be due to the hydrogen bonding of the β-estradiol to the β-CD cavity. The 





























as these were due to the hydroxide groups at carbons 2 and 3 on the cyclodextrin 
molecule. 
3.3.5 KβCD-MOF-1:Deoxycholic acid 
 
Figure 3-14: NMR Spectrum of Deoxycholic acid (top), KβCD-MOF-1 soaked 
with deoxycholic acid (middle) and KβCD-MOF-1 crystal (bottom). 
The two relatively adjacent methyl groups on the alkyl chain (6’) and the 
cyclopentenyl group (7’), with chemical shift of 0.55 ppm and 0.85 ppm,[59] were 
selected for deoxycholic acid to compare with the glycosidic protons of 
cyclodextrin shown in figure 3-14. The ratio of cyclodextrin to deoxycholic acid was 
21.06:3, i.e. 21:3. For every 1 deoxycholic acid there were 3 cyclodextrin 
molecules. Compared to cholesterol which has two hydrogen bonding sites at a 
hydroxide group and carbon-carbon double bond, deoxycholic acid has three 
areas for hydrogen bonding the two hydroxide groups and the carboxylic acid 

























were not present in the composite spectra as these were due to the hydroxide 
groups at carbons 2 and 3 on the cyclodextrin molecule. The signal broadening of 
the cyclodextrin peaks at 3.0-3.75 ppm and 4.75 ppm were due to the high 
abundance of protons which could not be distinguished. 
The up field shift observed in the NMR spectrum of CD:sterols could be a result of 
hydrogen bonding between the sterols and β-CD molecule.[60] The inner cavity 
protons of β-CD (located at positions C3 and C5) have chemical shift values in the 
regions of 3.5 to 3.7 ppm in the NMR spectra in this section. In all of the mixture of 
β-CD and sterol spectra, the inner β-CD proton chemical shifts, as mentioned 
above, were not distinguishable due to broadened peaks which could be due to 
formation of inclusion complexes or exchange processes.[60] 
The ratio of cholesterol to KβCD-MOF-1 crystal, shown in figure 3-10, was 
determined to be 1:2. Whist the crystal KβCD-MOF-1-Chol was found to have 
cholesterol occupancy of β-CD in a ratio of two β-CD molecules to one cholesterol 
molecule. Therefore it was concluded indirectly that the cholesterol being 
measured in figure 3-10 was bound to the inner channels of KβCD-MOF-1 
crystals. As for the other sterols, with the available NMR data alone, it was difficult 
to conclude if the sterols being measured were not surface-bound to the KβCD-
MOF-1 crystals because the peaks of interest for β-CD protons were 




Table 1: Summary of NMR uptake studies 
Sterol Chemical Shift / ppm Integration Ratio of sterol:β-CD 
Cholesterol 0.8 6.0 1:2 
Testosterone 5.7 1.0 1:4 
Β-estradiol 5.98, 6.05, 6.70 0.98, 1.08, 1.00 1:2 
Deoxycholic acid 0.55,0.85 3.7,3.0 1:3 
 
The results summarised in table 1 obtained from the NMR uptake studies showed 
the new KβCD-MOF-1 network was able to uptake cholesterol and similar 
analogues of sterols. In section 3.1.4 KβCD-MOF-1-chol showed occupancy of 
cholesterol to be one cholesterol molecule per two molecules of β-CD. This was 
also confirmed by the NMR which showed 1:2 ratio of cholesterol:β-CD. The other 
sterols (testosterone, β-estradiol and deoxycholic acid) showed varying ratios to β-
CD, after 24 hours of soaking. The ratio of testosterone, β-estradiol and 
deoxycholic acid to β-CD were 1:4, 1:2 and 1:3 respectively. The more 
electronegative functional groups present in the structure of the sterols the greater 
the ratio of β-CD:sterol. This indicates that the intake of the highly electronegative 
sterol was less than cholesterol as the number of β-CD per molecule increased. 
As the concentrations of the sterols were the same, testosterone and deoxycholic 
acid were taking up more space in the crystal pores compared to β-estradiol and 
cholesterol. 
3.4 Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) was performed on KβCD-MOF-1 (Figures 3-15 
and 3-16) to determine the thermal stabilities. Measurements were carried out 
under an air atmosphere, resulting in decomposition of the cyclodextrin occurring 
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from 250°C. Comparison of the samples, dried in two different methods, showed 
near identical loss of mass in the temperature range of 50-450°C. 
Figure 3-15 shows the plotted data for the TGA analysis of the KβCD complex 
dried in air; here the loss in mass was recorded with respect to increase in 
temperature. The initial sample mass was 27.4 mg. As the temperature increased 
from 30-100°C a loss of 10% was observed and was due to loss of residual 
solvent within the crystals as the boiling points of methanol/ethanol/water were up 
to 100°C. A 50% mass loss was observed in the region of 220-320°C this was due 
to the thermal degradation of β-Cyclodextrin.[61] 
 
Figure 3-15: Thermogravimetric analysis of KβCD-MOF-1 network dried in 
air. 
Figure 3-16 shows the plotted data for the TGA analysis of the KβCD complex 
dried in vacuum (using a schlenk line); here the loss in mass with respect to 
increase in temperature was recorded again. The initial sample mass was 8.1 mg. 
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was due to loss of residual solvent within the crystals as the boiling points of 
methanol/ethanol/water were up to 100°C. A 50% mass loss was observed in the 
region of 220-320°C this was due to the thermal degradation of β-Cyclodextrin.[61] 
 
Figure 3-16: Thermogravimetric analysis of KβCD-MOF-1 network dried in 
vacuum. 
Both of the thermogravimetric plots showed that the different methods of drying 
the crystal samples yielded very similar result even when the mass of sample used 
was different. This showed that due to the structure being made of layered β-CD 
nanotube channels some solvent was always retained within the crystal complex 
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3.5 KβCD-MOF-1 Crystal Imaging Analysis 
The KβCD-MOF-1 network have been observed by eye, by optical microscope to 
see shapes of the crystals that had formed and even analysed by X-ray diffraction 
to determine the structural arrangement of the molecules and atoms it was 
composed of. One aspect which was not initially considered was the surface 
topography of crystals. In order to see the crystal topography, a scanning electron 
microscope was used to obtain back scatter and secondary electron images of the 
crystals at a micrometre scale. 
The following figures (3-17 to 3-20) show various images of KβCD-MOF-1 crystal. 
One significant aspect which was seen only with the use of SEM was that what 
appeared to be single long needle like crystals by eye was actually made up of a 
series of layered crystals similar to fallen dominoes. The latter two figures show 
clearly that the larger crystal structure began from a central area. 
 
Figure 3-17: SEM image of KβCD-MOF-1 crystal showing long needle 




Figure 3-18: A full view of a KβCD-MOF-1 crystal (secondary electron image) 
again showing the whole of the crystal being composed of highly layered 
structures. 
 
Figure 3-19: Back Scatter electron image of KβCD-MOF-1 crystal showing 
the point from which the crystal grew outwards, additionally layering of the 




Figure 3-20: Secondary electron image of the nucleation point of the KβCD-
MOF-1 crystal the topography can be seen clearly, a central mass of crystal 
initially formed then as the crystal was left to nucleate the starburst effect 
occurred in which layering of the needle strands can be seen. 
3.5.1 Imaging KβCD-MOF-1 soaked in Topfluor cholesterol 
It was observed that KβCD-MOF-1 network was able to be soaked in a solution of 
cholesterol over a 24 hour period without changing the crystal morphology. 
Additionally when KβCD-MOF-1 was made using solvent diffusion in the presence 
of cholesterol KβCD-MOF-1-chol was made. Both of these networks showed that 
the ratio of cholesterol:β-CD was 1:2. Therefore, topfluor cholesterol was used in a 
similar study to see what would happen to KβCD-MOF-1 after being soaked for 24 
hour period. 
After soaking KβCD-MOF-1 crystals in topfluor cholesterol images were taken in 
bright field and blue LED excitation, shown in figure 3-21, after being washed in 
ethanol. In blue fluorescence it was seen that the crystals were much brighter than 
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the surrounding medium which indicated that topfluor cholesterol was retained on 
the crystal. 
  
Figure 3-21: Images taken on the lumascope of KβCD-MOF-1 crystal which 
was washed twice using 1ml ethanol after being soaked in topfluor 
cholesterol for 24 hours (Left in bright field/white light and right in dark blue 





Figure 3-22: More detailed images of another KβCD-MOF-1 crystal which was 
washed twice using 1ml ethanol after being soaked in topfluor cholesterol 
for 24 hours (Left in blue light and right in brightfield/white light). 
The results (figures 3-21 and 3-22) showed that KβCD-MOF-1 network in addition 
to up taking cholesterol was also able to retain topfluor cholesterol when soaked in 
solution. Both figures 3-21 and 3-22 show the surface of KβCD-MOF-1 crystal. In 
the latter case more surface details could be seen. The areas of high intensities in 
figure 3-22 represent higher concentration of topfluor in those areas. Additionally 
this top down view of the crystal showed more intense fluorescence along the 
edges of the crystal network. 
The bright field image (right hand side of figure 3-22) shows what appears to be 
cracks or irregularities on the surface of the KβCD-MOF-1 crystal, this may have 
occurred due to exposure of the crystal to air, or even when washed with ethanol. 
The images taken after the soakings were in ethanol, it was seen that the 
fluorescent intensity decreased as more time went on. This, along with higher 
intensities at the edges of the crystal, suggested that topfluor cholesterol was 
binding to the surface of the crystals and ethanol was displacing the cholesterol 
after soaking.  
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Therefore, as topfluor cholesterol contained the bodipy group and normal 
cholesterol was shown to be up taken fully into β-CD cavity, mixtures of such 
compounds could be used as a potential method to induce a controlled uptake of 
similar compounds into the newly formed KβCD-MOF-1 network. 
As described in section 1.3 these molecules have also been utilised in biosciences 
to visualise processes such changes in membrane curvature during viral budding. 
3.6 Vesicles and encapsulation 
Vesicles have been used in a wide range of studies, ranging from studies of 
membrane processes to acting as artificial cells used for drug delivery. Metal 
Organic Frameworks have also shown to be effective to be used in drug delivery. 
One aspect which has yet to be shown is the merging of both materials to make a 
biocompatible system which could potentially be used as a rapid delivery system 
or as a chemical/toxic removal system. 
Figure 3-23 shows some images of vesicles made using 1,2-ditetradecanoyl-sn-
glycero-3-phosphocholine (DMPC) lipid and topfluor cholesterol after the 
electroformation process taken on an Etaluma Lumascope 620 digital microscope 
made throughout the duration of this project. The excitation wavelength was in the 
range of 473-491 nm and emission wavelength was in the region of 502-561 nm. 
In the four images (figure 3-23) vesicles can were seen clearly in a dark 
environment using a blue LED source. The vesicles formed were random in size 
with some being 10µm and others were larger with additional vesicles inside. As 
described in section 1.3, electroformation is quick process and yields vesicles of 
various sizes this can be seen in figure 3-23. The areas of high fluorescent 
intensity are more intense in contrast to the surrounding medium, this indicates 
regions of highly concentrated topfluor cholesterol or where vesicles have 
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aggregated. The electroformation method used for making these vesicles showed 
that so long as an alternating current source was available, it was possible to 
make GUVs with readily available materials. 
 
Figure 3-23: Various images of vesicles made using DMPC lipid with 
0.1mol% incorporated topfluor cholesterol taken on the lumascope. The 
scale bars on the images are 10 µm at 100× magnification. 
Previous to this study, there was no recorded literature which in MOFs had been 
encapsulated within vesicles. Therefore, using UiO-66 crystals made in the Blight 
group; encapsulation of UiO-66 was attempted to see if it would be possible to see 
both crystal and vesicle structures clearly. 
A known MOF, UiO-66, was used to try to encapsulate into vesicles. This was 
done by adding UiO-66 to the electroformation buffer then using this in the stage 
of re-suspending lipids prior to electroformation. Initial viewing of the results under 
the lumascope (figure 3-24) showed that when viewed under bright field the UiO-
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66 MOF crystals were clearly seen, whilst in blue light excitation the vesicles were 
seen to be surrounding the position of the crystal clusters. 
 
Figure 3-24: Brightfield image showing UiO-66 MOF crystals (left) and the 
same image in blue light excitation showing vesicles (right) taken after 
electroformation with UiO-66 MOF crystals present in solution. The scale 
bars on the images are 10 µm at 100× magnification 
TEM was used to see if encapsulation of MOFs was successful. Preliminary image 
captured (Figure 3-25) showed that the crystals were clustered centrally because 
the arrangements of the crystals were circular. As the contrast is higher around the 
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circumference of the crystals it could be an indication that a membrane is 
surrounding the crystals. However there were no empty vesicles visible. 
 
Figure 3-25: Preliminary TEM image of UiO-66 MOF crystals captured after 
encapsulation with in unilamellar vesicle. 
Although from figure 3-24 there is an indication that encapsulation was there 
however from figure 3-25 it cannot be concluded conclusively if the encapsulation 
of UiO-66 with in vesicles had taken place. Additionally as far as our 
understanding was this was the first attempt to incorporate crystals inside vesicles 
rather than on the outer or inner surfaces of membranes. 
Sometimes it is possible to get drying artefacts when preparing samples for TEM 
analysis.[62] These can occur during the sample preparation when dispersed 
samples are dried on a TEM grid but residual liquid is retained on the surfaces of 
samples of interest. This can lead to possible coffee ring effects wherein there 
could be dark patches around the perimeter of samples viewed under TEM. With 
only the image seen in figure 3-25, it was not possible to confirm if the dark 




4. Conclusions and Future Work 
4.1 Conclusions 
Metal organic framework, as defined by IUPAC guidelines is a coordination 
network with organic ligands which contain potential voids. 
A new beta-cyclodextrin-potassium network named KβCD-MOF-1 and two other 
analogues KβCD-MOF-1-Chol and KβCD-MOF-2 were made successfully. The 
crystal structures of the new network and other β-CD crystals were analysed by X-
ray diffraction. The new 1:20 β-CD:K KβCD-MOF-1 crystal is made of layers of 
cyclodextrin channels which are stacked perpendicularly from one layer to the 
next. The control cyclodextrin crystals show a stacking formation by which the 
cavity of the cyclodextrin is inaccessible due to an offset arrangement of the β-CD. 
When cholesterol is added in the 1:20 mixture before crystal formation, a new 
crystal was formed named KβCD-MOF-1-Chol. This structure looked like a 
honeycomb and within the cavity of every 6 β-CD molecules 1 cholesterol 
molecule was observed. A 1:1 ratio of β-CD:potassium benzoate resulted in 
another structure named KβCD-MOF-2. This was similar to a previous inclusion 
complex but was unique due to the crystal lattice being made by solvent diffusion 
rather than solvent evaporation.  
The morphologies of the control β-CD crystals and KβCD-MOF-1 crystals were 
tested by placing these into a solution of cholesterol in order to investigate any 
changes to the physical properties of the crystals; the former was seen to have 
nucleation of cholesterol on the edge of the structure after soaking, whilst the 
KβCD-MOF-1 crystals remained unchanged throughout the soaking. Hence the 




The uptake of cholesterol and several other sterols (testosterone, β-estradiol and 
deoxycholic acid) were performed on the newly formed KβCD-MOF-1 network by 
soaking the crystal in a solution of the respective sterol. The ratio of sterol:β-CD 
was determined using proton NMR analysis. The results were cholesterol:β-CD 
was 1:2, testosterone:β-CD was 1:4, β-estradiol:β-CD was 1:2 and dexoycholic 
acid:β-CD was 1:3. The results showed that uptake of these sterols were 
successful. The NMR results also showed an inverse relation between numbers of 
polar groups in the sterol to the uptake by KβCD-MOF-1 network. 
The preliminary results obtained for the vesicle encapsulation study using UiO-66 
crystals could not be concluded. The fluorescent and bright field images on the 
lumascope showed clusters of crystals in the same regions as vesicles. However 
additional testing will be required to conclusively confirm if the methods used for 
encapsulation of UiO-66 crystals with in vesicles had been completed. 
4.2 Future work 
The discovery of a new material, be it a crystal or otherwise, brings forth many 
new challenges to discover what it can do, how stable it could be in ambient 
conditions and what would happen in extreme conditions. 
The greatest limitation to such a research project was time. With the time available 
in this project the decision was taken to investigate uptake of cholesterol and 
some other similar analogues with the sterol back-bone. To carry on with further 
analysis of the various crystals, the porosity could have been modelled using the 
crystal structure (theoretical) and then carried out using nitrogen adsorption 
(experimental) this would have provided data of how much of the internal volume 
of the network could be available. Uptake studies would have been carried out 
using a mixture of compounds (such as a mixture of cholesterol and estradiol) to 
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see if the crystal would either separate similar substances or if uptake would be 
favoured by one molecule over another. This in turn could be used to see if the β-
CD networks could be used to isolate and remove specific molecules such as 
cholesterol or perhaps be used to separate mixtures which otherwise may need to 
be treated to isolate. Using compounds which have different dyes could also be 
used to determine if inclusion complexes of KβCD-MOF-1 can be used to uptake 
certain quantities of one molecule and then be capped by a second molecule. This 
would be beneficial in pharmaceuticals as a potential rapid drug delivery medium. 
Ethanol was found to be the medium in which the new β-CD crystals remained 
intact, additional testing to determine an ideal medium in which these networks 
would remain most stable other than ethanol could allow the use of these networks 
in fields such as medical treatments (as KβCD-MOF-1 was able to uptake sterols 
such as cholesterol and testosterone).  
This project has demonstrated that unaltered β-CD can be used to make novel 
porous coordinate networks. Additionally cholesterol and 3 sterols have been 
bound to a new porous β-CD network. Although MOF crystals were not confirmed 
to be encapsulated within vesicles, the work in this project could lead towards 
research to uses of MOFs in tandem with vesicles in applications including but not 
limited to, transport of essential materials, removal of toxins or hazards, direct-to-
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Tables 2 to 4 show the data obtained by Dr Shepherd, to form the structural 
models for Kβ-CD-MOF-1, Kβ-CD-MOF-1-Chol and Kβ-CD-MOF-2. 
Table 2: Crystallographic data comparisons of Kβ-CD-MOF-1 
 
Calculated Reported 
Volume 6733.1(5) 6733.1(5) 
Space group P 1 P 1 
Hall group P 1 P 1 
Moiety formula 
C168 H280 K9 O149, 2(C H4O), 
13(O) 
2.25(K), C42 H70 O35, 5.5(O), 0.5(C 
H4 O) 
Sum formula C170 H288 K9 O164 C42.50 H72 K2.25 O41 
Mr 5307.84 1326.97 
Dx,g cm-3 1.309 1.309 
Z 1 4 
Mu (mm-1) 0.452 0.462 
F000 2791 2791 
F000’ 2797 
 
h,k,lmax 19,19,37 19,19,37 
Nref 55448[ 27724] 50757 






Theta (max) 33.695 
R (reflections) 0.1136 ( 35439) 
wR2 
(Reflections) 






Table 3: Crystallographic data comparisons of Kβ-CD-MOF-1-Chol 
  Calculated  Reported 
Volume  6943.73(11)  6943.73(11) 
Space group  P 21  P 1 21 1 
Hall group  P 2yb  P 2yb 
  C84 H139 K2.55 O74.50, C84 H139 K2 O72.5, 
Moiety formula 0.32(C27 H46 O), O0.50,O0.50, 2(O0.50), 0.55(K), 9(O), 0.32(C27 H46 O) 
Sum formula  C92.64 H153.72 K2.55 O81.82 C92.64 H153.72 K2.56 O81.82 
Mr  2676.55 2676.57 
Dx,g cm-3  1.28 1.28 
Z  2 2 
Mu (mm-1)  1.651 1.651 
F000  2825.3 2825 
F000’  2838.43   
h,k,lmax  18,28,22  18,28,22 
Nref  24538[ 12586]  24291 
Tmin,Tmax  0.742,0.820  0.806,1.000 




Theta (max) 66.596 
R (reflections) 0.1051 ( 22829) 
wR2 
(Reflections) 







Table 4: Crystallographic data comparisons of Kβ-CD-MOF-2 
  Calculated  Reported 
Volume  3428.78(8)  3428.78(10) 
Space group  P 1  P 1 
Hall group  P 1  P 1 
Moiety formula  
C84 H164 K3 O82, 3(C7 H5 O2), 8(H2 
O) 
C84 H168 K3 O84, 3(C7 H5 
O2), 6(H2 O) 
Sum formula  C105 H195 K3 O96  C105 H195 K3 O96 
Mr  3110.92 3110.9 
Dx,g cm-3  1.507 1.507 
Z  1 1 
Mu (mm-1)  1.953 1.953 
F000  1650 1650 
F000’  1657.65   
h,k,lmax  17,18,18  17,18,18 
Nref  24252[ 12126]  21960 
Tmin,Tmax  0.777,0.790  0.923,0.944 




Theta (max) 66.594 
R (reflections) 0.0282 ( 21567) 
wR2 (Reflections) 0.0739 ( 21960) 
S 1.023 
Npar 1931 
 
 
